Get the Stockscreener App
6.24
1.73%
-0.11
Inogen Inc stock is traded at $6.24, with a volume of 471.56K.
It is down -1.73% in the last 24 hours and down -11.36% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$6.35
Open:
$6.34
24h Volume:
471.56K
Relative Volume:
1.44
Market Cap:
$193.59M
Revenue:
$331.52M
Net Income/Loss:
$-52.69M
P/E Ratio:
-2.7733
EPS:
-2.25
Net Cash Flow:
$-14.47M
1W Performance:
-13.33%
1M Performance:
-11.36%
6M Performance:
-43.73%
1Y Performance:
-28.19%
1-Day Range:
$6.00
$6.485
1-Week Range:
$5.745
$7.29
52-Week Range:
$5.745
$13.33
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.24 | 193.59M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Market Momentum: Inogen Inc (INGN) Registers a -11.44 Decrease, Closing at 6.35 - DWinneX
Inogen Insiders Lose Out As Stock Sinks To US$6.35 - simplywall.st
Inogen Inc’s Mixed Q1 2025 Earnings Call Insights - TipRanks
Inogen Inc SEC 10-Q Report - TradingView
INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y - TradingView
Inogen (INGN): Stifel Adjusts Price Target Amid Maintained Hold Rating | INGN Stock News - GuruFocus
Inogen, Inc. (NASDAQ:INGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Inogen targets $352M-$355M in 2025 revenue with focus on B2B growth and strategic innovations - MSN
Inogen reports net loss of USD 6.2M in Q1 2025 - Medical Buyer
Inogen reports net loss of USD 6.2M Q1 2025 - Medical Buyer
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Barclays PLC - Defense World
Inogen Inc earnings beat by $0.36, revenue topped estimates - Investing.com Nigeria
Inogen Inc (INGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... - Yahoo Finance
Envestnet Asset Management Inc. Cuts Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Inc (INGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Partnerships Amid Challenges - GuruFocus
Inogen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Inogen sees Q1 2025 revenue rise, stock up 3.91% - Investing.com
Inogen Reports Improved Q1 2025 Financial Performance - TipRanks
Inogen: Q1 Earnings Snapshot - MySA
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings - Nasdaq
Inogen Q1 2025 slides: adjusted EBITDA reaches breakeven as B2B sales surge By Investing.com - Investing.com South Africa
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Inogen Q1 2025 slides: adjusted EBITDA reaches breakeven as B2B sales surge - Investing.com India
Inogen (INGN) Exceeds Revenue Expectations in Q1 | INGN Stock News - GuruFocus
Inogen Announces First Quarter 2025 Financial Results - Bluefield Daily Telegraph
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN - TradingView
Inogen (INGN) to Release Quarterly Earnings on Wednesday - Defense World
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Geode Capital Management LLC Cuts Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Russell Investments Group Ltd. Decreases Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - Defense World
Oxygen Therapy Market to Hit USD 47.6 Billion by 2031 | Growth Fueled by GE Healthcare & Inogen - openPR.com
Inogen Announces Third Quarter 2024 Financial Results - ADVFN
JPMorgan Chase & Co. Lowers Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - MSN
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 | INGN Stock News - GuruFocus
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025 - The Joplin Globe
American Century Companies Inc. Has $503,000 Stock Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Sei Investments Co. Takes Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC - Defense World
Inogen, Inc. (NASDAQ:INGN) Shares Acquired by Arrowstreet Capital Limited Partnership - The AM Reporter
Inogen stock touches 52-week low at $6.4 amid market challenges - Investing.com Canada
Inogen stock touches 52-week low at $6.4 amid market challenges By Investing.com - Investing.com South Africa
Inogen at Needham Conference: Strategic Growth Amid Challenges - Investing.com
Inogen at Needham Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
(INGN) Technical Data - news.stocktradersdaily.com
Prudential Financial Inc. Grows Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Favourable Signals For Inogen: Numerous Insiders Acquired Stock - Yahoo Finance
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):